[Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case]

Kyobu Geka. 2004 Mar;57(3):229-32.
[Article in Japanese]

Abstract

A 62-year-old man with supraventricular/ventricular tachycardia associated with myocardial infarction developed tachycardia during beating coronary artery bypass grafting (CABG). Intravenous administration of an ultra short acting beta-blocker, landiolol hydrochloride, controlled heart rate and improved tachyarrhythmia without significant change of blood pressure. Landiolol hydrochloride is effective and useful for the treatment of tachyarrhythmia during beating CABG.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage*
  • Coronary Artery Bypass* / methods
  • Humans
  • Infusions, Intravenous
  • Intraoperative Complications / drug therapy*
  • Male
  • Middle Aged
  • Morpholines / administration & dosage*
  • Tachycardia / drug therapy*
  • Treatment Outcome
  • Urea / administration & dosage*
  • Urea / analogs & derivatives*

Substances

  • Adrenergic beta-Antagonists
  • Morpholines
  • landiolol
  • Urea